New York Cannabis Sales Projected to Reach $2 Billion in 2026, but Most of the Market Remains Unlicensed
New York cannabis regulators project approximately $2 billion in licensed marijuana sales and $350 million in tax revenue for 2026. Despite rapid industry growth, the legal market captures less than one-third of estimated statewide cannabis demand, highlighting continuing challenges involving unlicensed sales, declining prices, and competition.

CONSUMPTION NEWS NETWORK | CANNABIS BUSINESS & ECONOMICS
New York Cannabis Sales Projected to Reach $2 Billion in 2026, but Most of the Market Remains UnlicensedNEW YORK | November 14, 2026 | Consumption News Network
New York's legal cannabis industry is on track to generate approximately $2 billion in sales during 2026, marking another significant milestone for one of America's largest marijuana markets. But behind the impressive numbers lies a more complicated reality: licensed businesses are still capturing less than one-third of the state's estimated cannabis demand.
According to figures presented by officials from the New York Office of Cannabis Management, the state's regulated marijuana industry is projected to generate approximately $350 million in tax revenue this year.
The projections reflect continued growth in licensed dispensaries, consumer spending, and the broader cannabis economy.
However, regulators estimate that New York's total marijuana market is worth between $6 billion and $7 billion annually.
That means billions of dollars in cannabis purchases may still be taking place outside the state's licensed retail system.
For lawmakers, regulators, entrepreneurs, and investors, the figures raise an important question: How can a legal cannabis industry generate billions in revenue while leaving most of its potential marketplace outside the regulated system?
New York's Legal Cannabis Industry Continues Growing
New York legalized adult-use marijuana in March 2021 through the Marijuana Regulation and Taxation Act.
The legislation established a framework for licensed cultivation, manufacturing, distribution, and retail sales while creating programs intended to promote social and economic equity.
The state's first licensed recreational dispensary opened in December 2022.
Since then, New York has experienced significant growth in legal cannabis sales, despite licensing delays, regulatory disputes, and competition from unlicensed businesses.
According to reporting published November 13 by The Marijuana Herald, New York cannabis regulators now project approximately $2 billion in licensed marijuana sales during 2026.
The forecast follows approximately $1.69 billion in sales during 2025.
If achieved, the $2 billion figure would represent an increase of approximately 18% over the previous year.
That growth demonstrates that consumers are increasingly participating in the regulated marketplace.
But the state's cannabis industry is still far from capturing its full economic potential.
A $6 Billion to $7 Billion Market
During a presentation to North Carolina's Advisory Council on Cannabis, New York Office of Cannabis Management Executive Director John Kagia and Chief Operating Officer Patrick McKeage discussed the size of the state's marijuana marketplace.
Officials estimated total annual cannabis demand at approximately $6 billion to $7 billion.
Compared with the projected $2 billion in licensed sales, that suggests the regulated industry accounts for roughly 29% to 33% of the overall market.
The remaining demand is estimated to exist outside licensed retail channels.
That does not mean every unregulated transaction can be individually identified or measured. Total market estimates necessarily involve assumptions about consumer behavior and spending.
Nevertheless, the gap between licensed sales and estimated demand is substantial.
It suggests that New York's legal cannabis industry has considerable room to expand if more consumers transition into regulated retail channels.
It also illustrates the challenges facing states that legalize marijuana after an established underground marketplace has operated for decades.
Legal Cannabis Sales Reach New Milestones
New York's licensed marijuana businesses recorded approximately $512.6 million in sales during the third quarter of 2026.
That brought statewide sales through September to approximately $1.41 billion.
Since recreational sales began in December 2022, New York has generated more than $4.1 billion in cumulative licensed marijuana sales.
Those figures demonstrate the growing economic significance of cannabis legalization.
They also reflect increasing consumer access as additional dispensaries open throughout the state.
By late October 2026, New York had approximately 744 operating adult-use dispensaries.
The broader industry included more than 2,350 licensed businesses involved in cultivation, processing, distribution, retail, and related activities.
Each new business represents potential employment, investment, commercial activity, and tax revenue.
However, expanding the number of licensed businesses does not automatically guarantee profitability.
As more operators compete for customers, pricing and operating expenses become increasingly important.
Cannabis Prices Are Falling Across New York
One of the most significant developments in New York's cannabis market is the decline in retail marijuana prices.
According to the regulators' presentation, an eighth of an ounce of marijuana that previously cost approximately $70 to $75 before legalization can now be purchased for around $35 in the regulated marketplace.
That represents a substantial reduction in consumer prices.
Officials also reported that cannabis prices declined approximately 20% during 2025 and another 15% during 2026.
Lower prices can benefit consumers and help licensed dispensaries compete with unlicensed sellers.
However, declining prices also place pressure on cannabis businesses.
Retailers must generate enough sales to cover rent, employee wages, insurance, security, compliance, taxes, and inventory expenses.
Cultivators and manufacturers face similar challenges as wholesale prices decline.
While New York's overall licensed sales have continued increasing, individual businesses may experience shrinking margins.
For smaller operators, especially those with limited access to financing, that pressure can become significant.
Why So Much Cannabis Remains Outside the Licensed Market
The persistence of unlicensed cannabis sales is one of the most important challenges facing New York regulators.
Several factors may contribute to the situation.
1. Established Consumer Relationships
Before legalization, consumers developed purchasing relationships through informal and underground cannabis markets.
Those relationships do not necessarily disappear when licensed dispensaries begin operating.
Some consumers continue purchasing from familiar sources because of convenience, price, product availability, or personal preference.
2. Uneven Retail Access
Although New York has expanded its licensed dispensary network, access remains uneven across different communities.
Consumers who live far from a licensed retailer may find alternative sources more convenient.
As the legal retail footprint expands, that situation could gradually change.
3. Taxes and Compliance Costs
Licensed cannabis businesses must comply with regulatory requirements that can increase operating costs.
Those requirements include product testing, inventory tracking, security, licensing, and taxation.
Unlicensed sellers may avoid many of those expenses.
That difference can make it difficult for legitimate businesses to compete on price.
4. Regulatory Delays
New York's cannabis rollout experienced licensing delays, litigation, and administrative challenges.
During those delays, unlicensed businesses continued serving consumer demand.
The result was a marketplace in which unauthorized sellers established or maintained customer relationships before licensed retailers became widely available.
New York Has Changed Its Cannabis Tax System
Taxation remains a major part of New York's cannabis regulatory framework.
In June 2024, the state replaced its original THC potency-based wholesale tax with a 9% tax based on the value of marijuana products sold to retailers.
The change simplified tax administration and addressed concerns about inconsistent laboratory potency measurements.
New York also imposes a 9% state retail cannabis tax and a 4% local retail cannabis tax.
These taxes contribute to the state's projected cannabis revenue.
However, taxation also affects the final price consumers pay.
Policymakers must balance the benefits of public revenue against the possibility that excessive retail prices could discourage consumers from purchasing through licensed businesses.
That balance is especially important in a market where unlicensed sellers continue competing for customers.
Where Does the Cannabis Tax Revenue Go?
New York's cannabis legalization framework directs marijuana tax revenue toward several public purposes.
Revenue supports the Office of Cannabis Management and the administration of the state's regulated cannabis system.
Remaining funds are designated for programs that include:
- Community reinvestment initiatives
- Education and public awareness
- Substance use prevention and treatment
- Mental health services
- Programs supporting communities affected by previous marijuana enforcement policies
The projected $350 million in 2026 tax revenue represents a significant potential funding source.
However, projections should not be confused with final collections or amounts already distributed to individual programs.
The ultimate public benefit depends on actual revenue, administrative expenses, legislative allocations, and program implementation.
Social Equity Remains a Central Challenge
New York's legalization framework placed significant emphasis on social and economic equity.
The state established licensing opportunities intended to help individuals and communities disproportionately affected by previous marijuana prohibition policies.
That approach was designed to ensure that legalization created opportunities beyond established corporations and well-funded investors.
However, receiving a license is only one part of operating a successful cannabis business.
Entrepreneurs also need access to affordable commercial property, financing, suppliers, insurance, employees, and reliable customers.
Some social-equity businesses have faced challenges involving startup costs, licensing delays, and competition.
As New York's legal marketplace expands, regulators will need to evaluate whether equity-focused operators can build sustainable businesses.
Success should not be measured solely by the number of licenses issued.
Long-term business survival, profitability, and community economic benefits are equally important.
More Dispensaries Do Not Automatically Mean More Profits
New York's expanding retail network presents both opportunities and risks.
Additional dispensaries can improve consumer access, increase competition, and help redirect purchases toward regulated businesses.
But rapid expansion can also reduce sales per location.
For example, if the number of dispensaries grows faster than total consumer spending, the average revenue available to each store may decline.
That does not mean every business experiences the same results.
Store location, customer loyalty, operating efficiency, product selection, and pricing can produce substantial differences in performance.
Nevertheless, the relationship between licensing growth and consumer demand will become increasingly important as New York's cannabis industry matures.
Regulators and investors will need to distinguish between growth in statewide sales and the financial health of individual operators.
What New York's Market Means for Other States
New York's experience offers important lessons for states considering recreational cannabis legalization.
Legalization creates an opportunity to establish product safety standards, generate public revenue, and provide regulated access to cannabis.
However, passing legalization legislation does not automatically transfer existing consumer demand into licensed businesses.
States must also consider licensing timelines, retail availability, taxation, enforcement, and the cost of regulatory compliance.
New York's projected $2 billion in licensed sales demonstrates the economic potential of a large regulated cannabis market.
At the same time, the estimated $6 billion to $7 billion total marketplace shows how much demand may remain outside that system.
For states preparing to develop their own cannabis programs, the lesson is clear: creating a legal marketplace is only the beginning.
Building a competitive, accessible, and financially sustainable industry requires continued attention after legalization.
The Bigger Picture: A Billion-Dollar Industry Still Finding Its Footing
New York's cannabis industry has made substantial progress since recreational sales began in December 2022.
Licensed businesses have generated billions in sales, expanded consumer access, and contributed tax revenue to public programs.
But the market remains in a period of transition.
Declining prices, increasing competition, uneven retail access, and persistent unlicensed sales continue shaping the industry's development.
The state's challenge is no longer simply opening more dispensaries.
It is creating conditions in which legitimate businesses can compete effectively while consumers have convenient access to tested, regulated products.
That requires balancing enforcement with economic opportunity.
It also requires recognizing that small businesses and social-equity operators may face different financial challenges than large, well-capitalized cannabis companies.
A successful cannabis marketplace must be measured by more than total revenue.
Its long-term health also depends on whether businesses survive, workers benefit, consumers receive reliable products, and communities see meaningful returns from legalization.
What Happens Next?
New York's final 2026 cannabis sales figures will provide a clearer picture of whether the state achieves its projected $2 billion milestone.
Regulators will also continue monitoring tax collections, retail expansion, pricing trends, and the relationship between licensed and unlicensed sales.
For cannabis businesses, the coming year will likely bring additional competition as new dispensaries enter the market.
For policymakers, the challenge will be determining how to increase participation in the regulated industry without creating unsustainable conditions for licensed operators.
And for consumers, the expanding marketplace may bring greater product availability and more competitive prices.
New York is demonstrating that legal cannabis can generate billions of dollars in economic activity. But with most estimated demand still outside licensed retail channels, the state's greatest opportunity may not be creating new consumers. It may be bringing existing consumers into the legal marketplace.
Whether New York can accomplish that will help determine the future of one of America's largest cannabis industries.
Consumption News Network will continue monitoring New York's cannabis industry, state legalization programs, licensed dispensary growth, and the economic impact of marijuana regulation throughout the United States.
Sources and Additional Reading
-
The Marijuana Herald: New York Marijuana Regulators Project $2 Billion in Sales and $350 Million in Tax Revenue in 2026
November 12, 2026. Reporting on state regulators' sales projections, tax revenue estimates, dispensary counts, and total market demand.
-
IgniteIt: FireStarter Cannabis Industry News, November 14, 2026
November 14, 2026. Industry coverage of New York's projected sales, declining prices, and licensed market share.
-
CannIntel: New York Cannabis Rollout, Licensing, Equity Programs and Market Timeline
Updated November 13, 2026. Analysis of New York's licensing rollout, revenue forecasts, and competition from the unlicensed marketplace.
-
New York State: February 26, 2026 Joint Legislative Budget Hearing
February 26, 2026. Legislative testimony covering the development of New York's regulated cannabis market, licensing, and earlier sales forecasts.
